| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 9e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |